Recent advances in whole-genome sequencing have identified hitherto undiscovered mutations in cancers and identified recurrent loss-of-function and gain-of-dominant-negative function mutations in RhoA in lymphoma, leukemia and several solid tumors. The gene discussed is RHOA; the disease is cancer.